Business Description
Founded in 2013 and headquartered in Shanghai, China, Zai Lab is a biopharmaceutical company dedicated to developing and bringing to market treatments for cancer, autoimmune disorders, neurological conditions, and infectious diseases. The company sells several approved medicines targeting serious illnesses such as ovarian cancer, lung cancer, glioblastoma, and bacterial pneumonia, among others. Zai Lab works closely with a number of global pharmaceutical and biotech partners, including Pfizer and Boehringer Ingelheim, to jointly develop and commercialize a broad range of therapies across its focus areas.
